New Delhi, India

Suhail Ahmad

USPTO Granted Patents = 3 

Average Co-Inventor Count = 4.3

ph-index = 1


Company Filing History:


Years Active: 2010-2012

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Innovator Spotlight: Suhail Ahmad

Introduction: Suhail Ahmad, a prominent inventor based in New Delhi, India, has made significant strides in the field of pharmaceutical innovations. With a total of three patents to his name, his work has the potential to impact the way certain medications are formulated and prepared.

Latest Patents: Among Suhail Ahmad's latest patents are two notable inventions related to varenicline salts. The first patent focuses on the solid state forms of varenicline salts and the methods of their preparation. This includes the development of salts and crystalline forms, particularly Varenicline sulfate, along with processes to derive varenicline base from these salts. The second patent highlights the crystalline forms of Varenicline Tosylate, an essential intermediate in the preparation process of varenicline L-tartrate. This invention also details methods for obtaining high purity Varenicline base using Varenicline Tosylate.

Career Highlights: Suhail Ahmad has carved a niche for himself within the pharmaceutical industry, showcasing his expertise through his innovative contributions. His work at Teva Pharmaceutical Industries Limited underscores his commitment to advancing pharmaceutical formulations and improving therapeutic outcomes.

Collaborations: Throughout his career, Suhail has collaborated with talented professionals including Vinod Kumar Kansal and Maytal Piran. These partnerships have been instrumental in driving the success of his projects and enhancing the quality of his inventions.

Conclusion: Suhail Ahmad is a testament to the potential of innovation in the pharmaceutical sector. His patents not only reflect his technical prowess but also his dedication to improving healthcare solutions. As he continues his journey at Teva Pharmaceutical Industries Limited, the industry eagerly anticipates the impact of his future contributions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…